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Mixed Neural-Conventional Processing to
Differentiate Airway Diseases by Means of
Functional Noninvasive Tests
Marco Parvis, Senior Member, IEEE, Carlo Gulotta, and Roberto Torchio
Abstract—This paper describes a processing technique that
can be used to combine information from different medical
analyzes to discriminate between different pathologies that have
similar symptoms. The paper is focused on the differentiation
between asthma, bronchitis, and emphysema, using only func-
tional noninvasive tests, but the proposed technique can be easily
applied to other similar situations where different tests have to
be used to identify a pathology. The technique is based on mixed
neural-and-conventional processing that not only suggests the
pathology, but also estimates the reliability of this suggestion.
Index Terms—Health care, medical, neural networks, pro-
cessing, uncertainties.
I. INTRODUCTION
THE frequency of lung pathologies is continuously in-creasing due to several environmental causes, such as air
pollution, indoor contaminants, and smoking habits. Such an
increase, combined with the increased life expectancy, requires
methods to classify the different pulmonary diseases, but which
limit the use of costly diagnostic methods as much as possible.
Most functional, noninvasive tests are largely aspecific with
respect to pathologies that have similar symptoms at the ini-
tial stage, such as asthma, bronchitis and emphysema. For this
reason, no test alone allows a reliable discrimination to be per-
formed and, unfortunately, as of yet, no assessed model which
is able to meaningfully combine the data exists. This paper de-
scribes a mixed neural and conventional approach based on es-
timation of a “pathology evidence” index on the basis of four
lung functional parameters. The proposed approach takes the
uncertainty of the single tests into account and flags the pro-
cessing result with the probability of being the correctly identi-
fied pathology.
II. PATHOPHYSIOLOGY OF AIRWAY OBSTRUCTION
The identification of the three airway pathologies [1], on the
basis of noninvasive tests, is not an easy task. Airflow tests
are usually employed to highlight the presence of emphysema,
while respiratory tests, before and after bronchodilating sub-
stances, are normally employed to highlight the presence of
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asthma. Pulmonary emphysema is, in fact, characterized by
alveolar destruction and airflow limitation which does not
change after the use of bronchodilating substances, but, unfor-
tunately, airflow limitation is also often present in bronchitis
patients. Pharmacological reversibility of airway obstruction is
a typical feature of asthmatic patients, but chronic obstructive
pulmonary disease patients also show variable degrees of
response to bronchodilating agents.
A correct diagnosis of asthma, bronchitis, and emphysema
can, of course, be reliably obtained by means of clinical, radi-
ological, and functional assessment involving several tests, but
this would greatly increase the overall cost and time of the pro-
cedure required for the diagnosis.
The aim of this work was, therefore, to verify if a reason-
able and accurate prediction could be obtained by combining
the results of different simple spirometric data, which are col-
lected before and after pharmacological bronchodilation. Sev-
eral different tests have been proposed to discriminate between
the three pathologies [2]–[4]. After some tests, the authors de-
cided to use four of the tests most commonly found in literature.
Two tests concern lung parameters: the residual lung volume
(RV) and the transfer lung factor for carbon monoxide (TLCO).
The other two tests are related to the change of two respira-
tory parameters: forced expired volume in 1s ( ) and
the specific airway conductance ( ), before and after
inhalation of a broncodilator (200 mg of salbutamol). All the
test results were normalized to the standard predicted results ac-
cording to the European Respiratory Society (ERS) recomenda-
tions [5].
III. DATA PROCESSING
A. Population
The available data represented a population composed of 158
patients diagnosed according to the American Thoracic Society
(ATS) criteria. Of these, 37 were classified as asthmatic, 79 as
bronchitic, and 42 as being affected by emphysema. The data
were recorded in three different periods with different intrumen-
tation; 96 patients were monitored in 1997 and early 1998, 15
were monitored in January 1999, and the last 47 were monitored
in late 1999.
The patients were divided into two groups. One group of 55
patients (13 asthmatic, 29 bronchitic, and 13 affected by em-
physema), chosen from among the first 96 patients, was used
to estimate the statistical parameters and to train the networks;
0018–9456/01$10.00 © 2001 IEEE
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Fig. 1. Mean and standard deviation of the four measured parameters and of the three categories.
data of the remaining 103 patients (24 asthmatic, 50 bronchitic,
and 29 affected by emphysema) were used to validate the pro-
cedures.
The 55 patients included in the training set were selected by
the physicians in order to be representative of the different as-
pects of the three pathologies. Care was taken to ensure that a
reasonable number of examples of the three pathologies were
present in the training set to avoid polarized network behavior
[6], i.e., to prevent the network from adjusting the weights to
describe only the most common pathologies at the expense of
the others.
B. Linear Discriminant Score Approach
Fig. 1 shows the mean and standard deviation of the four clin-
ical tests of the patients included in the training set. The results
are clustered according to the pathology: a clear correlation be-
tween mean values and pathology is visible in each test even
though the standard deviations are rather large.
A correlation analysis has shown that the correlations are
below 0.5 with the exception of and ,
which reach the value of 0.52.
A patient classification was therefore attempted using a
Bayesian approach based on the linear discriminant scores [7].
Such a classification is often used in the medical field (see [8]),
and it tries to minimize error probability and cost by assigning
a “score” to each pathology
(1)
where
four-row vector, which contains the patient’s test re-
sults;
three-row vector of the three discriminant scores, one
per pathology;
three-row, four-column matrix;
three-row vector.
and are determined by means of the examples contained in
the training set
(2)
where
four-dimensional pooled covariance matrix of the tests
of the patients in the training set;
four-row three-column matrix, which contains the
mean values of each test in the training set, one column
per pathology;
three-row vector of the relative frequency of each
pathology in the training set, i.e., it is the a priori
probability of each pathology.
A patient is eventually assigned to the pathology with highest
score. The score-based classification was able to guess the right
diagnosis in 43 cases (78%) within the training set. Although
such a value is reasonably high for this kind of diagnosis, the
number of errors (12 cases corresponding to about 22%) is too
high for the method being currently used. Statistical procedures
are available to validate each result so that doubtful diagnoses
could be discovered, but a simpler approach would be desirable.
C. Neural Processing
No commonly accepted analytical model exists that can be
used to combine the test results to obtain the diagnosis. How-
ever the available examples can be used to train a multi layer
perceptron (MLP) neural network, thus overcoming the lack of
an analytical model and the problems related to unknown pop-
ulation distributions.
Several network structures can be adopted; all the networks
have to have four inputs (the four clinical values) but one can
decide to have either one single, three-level output (i.e., a single
output which assumes three values that correspond to the three
pathologies), or three outputs that activate each one in the pres-
ence of a specific pathology.
The authors decided to employ the latter solution, which has
two main advantages: a) the three separated outputs allow an
easier result interpretation in the presence of doubtful cases to
be obtained, and b) the network can be designed in the form
of three completely separated sub-networks, which are easier to
train.
Two neurons in the hidden layer were found to be sufficient
for the networks that had to recognize asthma and emphysema,
while three neurons were required for the network which
had to recognize bronchitis. All the networks were trained
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by employing a gradient-descend, back-propagation (Leven-
berg–Marquardt) algorithm [9].
Each network was trained to produce an unary output for pa-
tients who present the pathology the network had to recognize,
and a zero output otherwise. This kind of binary training, where
the examples presented to the network have either zero or one
target, tends to produce a switching network, especially when
the training set is limited [1]. This switching behavior is not cor-
rect in our situation, where there are examples of patients who
have clinical parameters on the borderline. Such an ambiguity
should be reflected also in the values of the MLP output.
This problem can be addressed either by adding noise to the
weight values during the training [11] or by adding noise to the
network inputs [12]. The authors employed a solution similar
to the one described in [13] using an algorithm that takes the
uncertainty presence into account [1]. The algorithm acts by re-
placing each element of the original training set with a sequence
of similar new elements that are composed of values which are
different from the original ones, within the expected uncertainty
of each input parameter.
The three outputs were eventually sent to a competitive layer
(CL), which simply employs a winner-takes-all strategy, i.e.,
it selects the network with the highest output, regardless of its
actual value.
By employing the three MLPs and the CL, the network
gives 47 correct results (85%) within the training set with only
eight errors (15%). The combination of MLP and CL therefore
performs better than the algorithm based on the discriminant
scores, but still suffers from a high number of errors. Such a
high number of wrong diagnoses is due to the nature of the
CL. The CL always produces a winner even though all the
competitors have a very low value, i.e., even though none of the
MLPs have actually recognized their pathology. This behavior
can be avoided by employing a modified CL, or some form of
more complex algorithms, that is capable of highlighting the
presence of doubtful winners.
D. Second-Level Conventional Processing
1) Output Validation Using the Guard Neuron: The CL be-
havior, which always produces a winner regardless of the winner
value, can be modified by adding a guard input (or guard neuron)
to the CL inputs. This guard input is a fixed input, set at a suit-
able level, which wins when all the other inputs are lower than
its guard level. The guard level selection should be performed
by trying to balance between the number of errors which can be
avoided and the number of good results which are missed due
to the activation of the guard.
Fig. 2 shows the guard neuron effect as a function of its value
for the patients within the control set. The three lines represent
the number of erroneous diagnoses, the number of correct di-
agnoses and the number of “unreliable” diagnoses that trigger
the guard neuron. As expected, as the guard level increases, the
number of errors decreases. A reduction of the erroneous diag-
noses to 2% can be obtained by employing guard levels above
0.8, but at the expense of about 60% of unclassified patients.
2) Output Validation Using the “Evidence Indexes”: The
guard neuron allows one to recognize conditions where none
Fig. 2. Erroneous diagnoses (thick line) and unclassified patients (thin line) as
a function of the guard level.
of the networks activate, but does not highlight situations
where more networks activate with similar values. In addition,
the guard neuron approach cannot highlight borderline cases
where the uncertainty, which affects the clinical test values, can
greatly alter the MLP outputs. Such problems can be reduced
by replacing the CL with an algorithm which highlights the
evidence of one pathology with respect to the others and takes
the uncertainty presence into account. A simple possibility is
to compute three evidence indexes by multiplying the output of
each network by the complements of the other two
(3)
where is a pathology index which uses a modulo-three algebra
(i.e, if then ).
Each evidence index can be tagged with its reliability by com-
puting its expected uncertainty as a function of the actual input
uncertainties. The uncertainty of the network inputs, i.e., the un-
certainties of the clinical parameters, can be estimated according
to the ATS criteria. The authors employed an uncertainty of 3%
of the expected range of each parameter. Such a value should
take all the uncertainty contributions into account and is rather
larger than the observed inter and intra-operator variability on a
single patient.
The sensitivities of each output with respect to each input de-
pend on the patient’s parameter combination and can be numer-
ically computed by examining the network outputs in the pres-
ence of small changes of each of the input parameters. A linear
approximation of network behaviors can be used since the input
uncertainties are small and the network functions do not con-
tain discontinuities. Therefore, the output standard uncertainty
can eventually be computed according to the conventional un-
certainty propagation rules [14]
(4)
where
combined standard uncertainty of th evidence index,
i.e., the expected standard deviation of th evidence
index;
standard uncertainty of the th clinical test;
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Fig. 3. Good diagnoses versus errors for different criteria.
sensitivity coefficient of the th evidence index with
respect to the th clinical test.
The covariance is neglected, since the four clinical param-
eters are measured using independent procedures and devices,
and, thus, their uncertainties can be considered statistically in-
dependent.
The three evidence indexes condense the amount of informa-
tion contained in the four original clinical parameters in a struc-
tured form, which is easier to manage with respect to the raw
data and allows the physician to comfortably carry out the diag-
nosis.
In addition, the uncertainty associated with each index allows
one not only to give an on/off response, but also to guess the
reliability of the pathology detection.
The physician can guess the reliability of the diagnosis by
using at least three different criteria
1) the actual value of the highest evidence index (low values
correspond to less reliable diagnoses);
2) the actual difference between the two higher indexes (low
differences correspond to pathologies with similar prob-
abilities of being recognized);
3) the uncertainty associated to each index (that can be used
to discriminate between indexes with similar values, but
which originate from more or less significant combina-
tions).
Each of these criteria can be used to employ a validation by
means of a threshold with an effect which is similar to the guard
neuron. Fig. 3 shows the number of good diagnoses versus the
number of errors for two criteria that combine index values and
uncertainties: the highest evidence index minus its uncertainty,
and the difference between the two higher indexes minus the
sum of their uncertainties. For comparison, the figure also shows
the trace obtained with the guard neuron.
The methods based on the evidence index exhibit similar re-
sults and perform better than the method based on the guard
neuron. This figure allows one to select the desired compro-
mise between the number of accepted errors and the number of
missed diagnoses.
(a)
(b)
Fig. 4. Evidence index performance on control (left) and training (right) sets
with three thresholds and in the absence of thresholds.
The two criteria can of course be mixed to find the combi-
nation that seems to be the most suitable to reduce the errors
while still maintaining the number of missed diagnoses at low
value. After some tests, the authors employed two contempora-
neous criteria, discarding results with either the evidence index
minus uncertainty below a predefined threshold, or the differ-
ence between indexes minus their uncertainties below a second
threshold. Three couples of thresholds were selected which cor-
responded to 4 (7%), 2 (4%), and 1 (2%) erroneous diagnoses
within the training set.
IV. EXPERIMENTAL RESULTS
Fig. 4 shows the performance of the proposed algorithm for
the three threshold choices, plus the results obtained in the ab-
sence of thresholds. In the absence of thresholds, the system
gives 23 (22%) errors and 80 (78%) correct results. Depending
on the threshold selection, it is possible to reduce the number of
erroneous diagnoses within the control set to 4% at the expense
of about 50% unclassified patients, or have 11% errors with 22%
unclassified patients. The figure also shows, on the right, the re-
sults obtained within the training set with the same thresholds.
Within the training set, the results are obviously better than in
the control set, especially on the number of unclassified patients,
thus suggesting that if more examples were available for both
training and testing, an enlargement of the training set could be
useful to improve the overall behavior.
The results obtained by the neural network plus the guard
neuron, and by the algorithm based on the discriminant scores,
PARVIS et al.: MIXED NEURAL-CONVENTIONAL PROCESSING 823
(a)
(b)
Fig. 5. Neural network and discriminant score performance on the control
(left) and training (right) sets.
Fig. 6. Panel of the program which computes the evidence indexes and their
uncertainties.
are shown in Fig. 5 for comparison purposes. The evidence
index method performs better than the other solutions, both in
the training set and the control set. A comparison for an equal
number of erroneous diagnoses shows that the number of not
classified patients is 10-15% higher with the guard neuron than
with the evidence index.
The score-based method, which can only be compared with
the neural network in the absence of the guard neuron, produces
nearly 50% more erroneous diagnoses than the neural network
both in the training set (22%) and in the control set (32%).
A simple program has been designed to allow an easy deter-
mination of the evidence index. The program, whose graphical
interface is shown in Fig. 6, has been coded in VisualBasic™
and is designed to be used in Windows9x/NT™ environments.
The program takes the four values that correspond to the four
clinical parameters and computes the three evidence indexes
with the estimated uncertainties. The network weights and pa-
rameter uncertainties are obtained from a file which can be up-
dated by the program that is used for the network training.
V. CONCLUSION
The discrimination between airway diseases with similar
symptoms at early stages can be reliably obtained using a
complete clinical, radiological, and functional assessment.
However, such a discrimination is much more difficult to obtain
when only functional, noninvasive tests have to be employed to
avoid unnecessary stress for the patients and to reduce the time
required for diagnosis.
This paper has presented a possible procedure to obtain such
a discrimination which is based on four simple respiratory tests.
The four test results are sent to three MLPs trained to recog-
nize the three pathologies. The network outputs are then com-
bined to define the diagnosis. Two different methods have been
presented. The most interesting results are obtained with the
method which estimates the evidence index of each pathology
and its uncertainty. Starting from these values, each patient is
tagged as either not classifiable or affected by one of the three
pathologies. The classification is performed by employing a set
of thresholds that can be chosen either to reduce the number of
erroneous diagnoses, at the expense of a greater number of un-
classified patients, or to reduce the number of unclassified pa-
tients at the expense of a greater number of erroneous diagnoses.
The proposed algorithm has been trained on a population of
55 patients and tested on another population of 103 patients.
Depending on the threshold choice, an error rate in the range
of 4% to 10% has been obtained in the control set with a rate
of unclassified patients in the range of 50% to 22%. A simple
program has been developed which implements the algorithm
and can be used to quickly estimate the patient’s situation and
decide if other tests should be performed.
An analysis of the performance difference within the training
and control sets suggests that even better results could be ob-
tained by enlarging the training set to better represent the dif-
ferent kinds of pathologies. The authors are collecting new data
to verify this possibility and will update the results as soon as a
reasonable number of new examples becomes available.
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